ARS Pharmaceuticals
SPRY----
ARS Pharmaceuticals (SPRY)
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internatio...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
ARS Pharmaceuticals Analyst Rating
View MoreForecast & Rating
Jul 13, 2026Price forecast
$26.75350.34%
Forecast & RatingStrong buy
4analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Tip Ranks · Jul 17 at 04:36 PM
ARS Pharmaceuticals Announces Key Executive Leadership Departures
- TradingView · Jul 17 at 03:03 PM
Richard Lowenthal resigns from ARS Board; Sarina Tanimoto departs as CMO
- Global Report · Jul 15 at 04:14 AM
M&A and Restructuring Surge Accelerates Across US Small-Caps
- prnewswire · Jul 9 at 04:38 PM
17:35 ETINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ARS Pharmaceuticals, Inc. - SPRY
- benzinga_article · Jul 9 at 12:37 PM
Can ARS Pharma's New CEO Unlock Neffy's Potential?
- TradingView · Jul 7 at 03:43 PM
ARS appoints Donn Casale as CEO, replacing Richard Lowenthal
